UNIVERSITE CLAUDE BERNARD - LYON 1;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS);HOSPIC;ENS - ECOLE NORMALE SUPERIEURE DE LYON;INSERM (INSTITUTE NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)
发明人:
Antoine SICARD,Olivier THAUNAT
申请号：
US15763566
公开号：
US20180280536A1
申请日:
2016.09.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to biofunctionalized nanoparticles and uses thereof in adoptive cell therapy. In particular, the present invention relates to a nanoparticle comprising an amount of at least one antigen and an amount of at least one antibody having specificity for a B cell receptor wherein the antigen and antibody are attached to the surface of the nanoparticle.
